/Investor DB

Colle Capital Partners — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Dandelion Healthdandelionhealth.aiinFeb 2024

Dandelion Health develops clinical AI applications by combining healthcare domain expertise with machine learning research to advance AI adoption in healthcare.

AI & Machine LearningDigital HealthHealthtechSyosset, US

Elliott Green(Co-founder and CEO)in

BoardSam Toole(Director)inNiyum Gandhi(Co-founder and Board Chair)inSendhil Mullainathan(Co-founder and Scientific Advisor)inZiad Obermeyer(Co-founder and Chief Scientific Officer)

Co-investorsConvergent VenturesFloating PointHealthier CapitalMoxxie VenturesPrimary Venture PartnersNew Enterprise Associates (NEA)

Emaema.aiJan 2024

Ema builds "Universal AI Employees" — AI agents designed to perform business tasks and automate repetitive work across an organization.

AI & Machine LearningEnterprise SoftwareFuture of WorkSaaS

Surojit Chatterjee(Co-Founder & CEO)inSouvik Sen(Co-Founder & CTO)in

Co-investorsAccelS32Section 32Transpose Platform ManagementWipro VenturesAME Cloud Ventures+7 more

Seamseam.coin𝕏May 2024

Seam provides an API platform that enables developers and businesses to connect applications with IoT devices and orchestrate their use.

Developer ToolsEnterprise SoftwareIoTPropTechSaaSSan Francisco, US

Dawn Ho(Founder)inSy Bohy(Founder)inSeve IbarluzeaKat Truong(Recruiter)Arynne Wexler(partnerships)Jared Saks(Technical Recruiter)

Co-investorsPioneerRoot Ventures Manager, LlcSoma CapitalTodd and Rahul’s Angel FundTuesday CapitalVortex Capital Partners+11 more

Seamtheseam.ukinMay 2024

The Seam offers specialist repair and alteration services for clothing, shoes, handbags, and knitwear, matching customers with a UK-wide network of skilled Makers.

Circular EconomyConsumerMarketplaces

Co-investorsJenson VenturesStation12Bessemer Venture Partnersf7 VenturesRitual CapitalUmami Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.